2025-2034 Drug Discovery Services Market Roadmap: Insights for Competitive Advantage

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Drug Discovery Services Market Size By 2025?
There has been a swift expansion in the market size of drug discovery services in the past few years. In terms of numbers, it is projected to climb from $18.27 billion in 2024 to $20.59 billion in 2025, marking a compound annual growth rate (CAGR) of 12.7%. The significant growth in the prior period can be credited to factors such as elevated investment in R&D, the growing burden of diseases, government subsidies and aid, the rise of contract research organizations (CROs), a shift towards personalized medicine, and strategies for drug repurposing.

How Big Is the Drug Discovery Services Market Size Expected to Grow by 2029?
In the coming years, the market size of drug discovery services is projected to witness remarkable growth, expanding to $33.88 billion by 2029 at a compound annual growth rate (CAGR) of 13.3%. The expected growth during this period can be linked to changes in regulatory frameworks, developments in drug delivery systems, rising focus on immunotherapy, the shift towards RNA-based therapeutics, and targeting of rare diseases. Forecast period trends include embracement of cutting-edge technologies, increased growth in biologicals and biopharmaceuticals, utilization of high-throughput screening, advances in virtual screening and emphasis on regenerative medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Which Key Market Drivers Powering Drug Discovery Services Market Expansion and Growth?
Emphasis on drug discovery trials is anticipated to boost the drug discovery services sector. The drug development life cycle plays a pivotal role in safeguarding effective and safe drug delivery. Hence, clinical trials are progressively becoming crucial in drug development. With the escalating importance of drug development and creativity in healthcare, the demand for drug discovery trials has increased globally. For example, according to ClinicalTrials.gov, a website for clinical trial registration, the total number of reported clinical trials was 452,604 in May 2023, reflecting an elevation from 365,000 registered trials reported in 2021. Thus, the increasing focus on drug discovery trials is expected to fuel the expansion of the drug discovery services market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Drug Discovery Services Market?
Leading businesses in the drug discovery services industry are pioneering sophisticated technologies like artificial intelligence (AI) and machine learning (ML) to improve both the proficiency and precision of the drug discovery process. AI and ML are interconnected domains of IT; AI pertains to the creation of digital systems capable of executing tasks that generally need human intelligence. ML, a component of AI, primarily employs algorithms and statistical models for computers to learn and make anticipations or choices using data. For instance, Eurofins Discovery, a French company providing services across numerous sectors including pharmaceuticals, unveiled an inventive platform known as DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation) in February 2024. This avant-garde platform employs proprietary datasets, AI, and ML to augment the process of drug discovery. SAFIRE aims to accelerate the unearthing of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) characteristics of molecules. The platform uses data from the comprehensive BioPrint database of Eurofins Discovery, which has been diligently compiled over many years of investigation.

What Are the Emerging Segments in the Drug Discovery Services Market?
The drug discovery services market covered in this report is segmented -

1) By Type: Chemistry Services, Biology Services
2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation
3) By Drug Type: Biologics Drug , Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:
1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization
2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp

Who Are the Global Leaders in the Drug Discovery Services Market?
Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Which are the Top Profitable Regional Markets for the Drug Discovery Services Industry?
North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8324

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.